Tata India Pharma & Healthcare Fund - Direct - Growth
Equity Scheme by Tata Asset Management Limited
3Y Returns (CAGR)
19.92%
Expense Ratio
0.99%
as of 01/07/2026
AUM
₹396.12 Cr
Qtr End: Mar 26
NAV
₹38.971
as of 17/07/2026
3Y Returns (CAGR)
19.92%
Expense Ratio
0.99%
as of 01/07/2026
AUM
₹396.12 Cr
Qtr End: Mar 26
NAV
₹38.971
as of 17/07/2026
Historical Performance
Investment growth and SIP performance over time.
Performance Metrics
Returns, CAGR, and Volatility.
| Period | Returns | CAGR | Volatility |
|---|---|---|---|
| 3M | 12.76% | 61.66% | 11.69% |
| 6M | 12.61% | 26.81% | 13.37% |
| 1Y | 9.04% | 9.04% | 12.04% |
| 3Y | 72.45% | 19.92% | 13.38% |
| 5Y | 101.99% | 15.10% | 13.16% |
Scheme Details
- Launch Date
- 04/12/2015
- Fund Age
- 10.6 years
- Minimum Investment
- ₹5,000
- Fund House
- Tata Mutual Fund
- Category
- Equity Scheme
- Sub-category
- Sectoral/ Thematic (Equity Scheme)
Similar Funds
Top funds in the same category and sub-category.
Aditya Birla Sun Life International Equity Fund - Direct - Growth
3Y CAGR19.08%
TER1.89%
AUM₹79.82 Cr
HDFC Defence Fund - Direct - Growth
3Y CAGR40.23%
TER0.82%
AUM₹2,010.92 Cr
DSP Natural Resources And New Energy Fund - Direct - Growth
3Y CAGR20.94%
TER1.06%
AUM₹803.01 Cr
DSP Banking & Financial Services Fund - Direct - Growth
3Y CAGR-
TER0.79%
AUM₹297.02 Cr
BANDHAN TRANSPORTATION AND LOGISTICS FUND - Direct - Growth
3Y CAGR20.41%
TER1.06%
AUM₹43.37 Cr
ICICI Prudential Commodities Fund - Direct - Growth
3Y CAGR16.83%
TER1.02%
AUM₹2,462.71 Cr
SBI BANKING & FINANCIAL SERVICES FUND - Direct - Growth
3Y CAGR17.79%
TER1.17%
AUM₹4,937.5 Cr